Jump to:

Syncona Fundamentals

Company Name Syncona Limited Last Updated 21 May 2019
Industry Financials Sector Equity Investment Instruments
Shares in Issue (m) 661.22 Market Cap (£m) 1,659.67
PE Ratio 321.80 Div per Share (p) 2.30
Div Yield 0.00 Div Cover 0.34
EPS 0.78 EPS Growth (%) -39.06
PEG -8.24 DPS Growth (%) 0.00
Debt Ratio 0.42 Debt Equity Ratio 0.29
Net Gearing 1.33 Gross Gearing 1.42
Asset Equity Ratio 1.01 Cash Equity Ratio 0.09
Quick Ratio 0.60 Current Ratio 0.60
Price To Book Value 1.57 ROCE 15.09

Syncona Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
H2 Dividend 21 Jun 2018 30 Jul 2018 GBX 2.30 2.30
H2 Dividend 20 Jul 2017 23 Aug 2017 GBX 2.30 2.30
H2 Dividend 14 Jul 2016 19 Aug 2016 GBX 2.20 2.20
H2 Dividend 16 Jul 2015 19 Aug 2015 GBX 2.10 2.10
H1 Dividend 06 Aug 2014 10 Sep 2014 GBX 2.00

Syncona Company Financials

Assets (£m) 2018 2017
Tangible Assets 0 0
Intangible Assets 0 0
Investments 1,065 896
Total Fixed Assets 1,065 896
Stocks 0 0
Debtors 5 5
Cash & Equivalents 1 0
Other Assets 0 0
Total Assets 1,071 901
Liabilities (£m) 2018 2017
Creditors within 1 year 11 6
Creditors after 1 year 4 0
Other Liabilities 0 0
Total Liabilities 15 6
Net assets 1,056 895
Equity (£m) 2018 2017
Called up share capital 763 760
Share Premium 0 0
Profit / Loss 160 136
Other Equity 293 135
Preference & Minorities 0 0
Total Capital Employed 1,056 895
Ratios 2018 2017
Debt Ratio 0.42 0.01
Debt-to-Equity 0.29 0.01
Net Gearing 1.33 0.67
Gross Gearing 1.42 0.68
Assets / Equity 1.01 1.01
Cash / Equity 0.09 0.01
EPS 0.78 1.28
Cash Flow (£m) 2018 2017
Cash from operating activities 8 7
Cashflow before financing 13 -158
Increase in Cash 1 0
Income (£m) 2018 2017
Turnover 0 0
Cost of sales 0 0
Gross Profit 0 0
Operating Profit 0 0
Pre-Tax profit 160 136
Profit / Loss for the year 763 760

Syncona Company Background

Sector Equity Investment Instruments
Activities Syncona Limited (formerly BACIT Limited) is a leading FTSE250 healthcare company focused on investing in and building global leaders in life science. Its vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
Latest Interim Date 21 Nov 2018
Latest Fiscal Year End Date 14 Jun 2018

Syncona Directors

Appointed Director Position
26 Oct 2012 Jeremy John Tigue Non-Executive Chairman
01 Apr 2018 Gian Piero Reverberi Non-Executive Director
20 Dec 2016 Dr Ellen Ruth Strahlman Non-Executive Director
26 Oct 2012 Nicholas David Moss Non-Executive Director
20 Dec 2016 Nigel John Keen Non-Executive Director
01 Nov 2017 Robert Hutchinson Non-Executive Director
26 Oct 2012 Thomas Alexander Gavin Henderson Non-Executive Director

Syncona Contact Details

Company Name Syncona Limited
Company Address 2nd Floor, 10 Aldermanbury, London EC2V 7RF.
Company Telephone +44 (0)20 3603 0453
Company Website http://www.synconaltd.com/

Syncona Advisors

Auditor Name Deloitte & Touche LLP
Auditor Address Regency Court, Glategny Esplanade, St. Peter Port, Guernsey GY1 3HW.
Auditor Website http://www.deloitte.com/
Auditor Telephone +44 (0)1481 724 11
Registrar Name Capita Registrars
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.capitaregistrars.com/
Registrar Telephone 0870 162 3100
Broker Name JPMorgan Cazenove
Broker Address 20 Moorgate, London EC2R 6DA.
Broker Website http://www.jpmorgancazenove.com/
Broker Telephone +44 (0)20 7588 2828
Adviser Name JPMorgan Cazenove
Adviser Address 20 Moorgate, London EC2R 6DA.
Adviser Website http://www.jpmorgancazenove.com/
Adviser Telephone +44 (0)20 7588 2828
Solicitor Name Freshfields Bruckhaus Deringer LLP
Solicitor Address 65 Fleet Street, London EC4Y 1HS.
Solicitor Website http://www.freshfields.com/
Solicitor Telephone +44 (0)20 7936 4000
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a